Bristol-Myers Squibb Company Congressional Trading
According to U.S. congressional financial disclosures filed under the STOCK Act, members of Congress have reported 251 trades in Bristol-Myers Squibb Company (NYSE: BMY) since 2014, across 45 members, worth an estimated $6.5M in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts). 118 buys against 132 sells, a modestly sell-led skew, with Democratic members responsible for 57% of the trades and Republican members 43%. The most recent disclosure shown was filed March 2026, and Ro Khanna has filed the most BMY transactions among those shown, with 8. Other recent filers include Gilbert Cisneros, Julie Johnson, and Virginia Foxx. One notable disclosed move was a purchase by Ro Khanna on June 23, 2025, up 27.8% since. These figures are drawn from public House and Senate periodic transaction reports and reflect what members were required to disclose, not the current market value of any position. Bristol-Myers Squibb Company's current Bullish Whales Tide Score is 44 out of 100 (Low Tide), Bottom 20% of universe (87); the Tide Score is generated algorithmically from public filings and market data and is not investment advice. For the full record, including the month-by-month buy and sell timeline, the party breakdown, top buyers and sellers, and every individual filing, see the Bristol-Myers Squibb Company (BMY) stock overview and the complete trade table below.
Data updated
Price & congressional trade timeline
Party breakdown
Bristol-Myers Squibb congressional trading activity
| Politician | Published | Traded | Filed After | Type | Size | Return | |
|---|---|---|---|---|---|---|---|
 Ro Khanna House | Mar 9, 2026 | Feb 5, 2026 | 32 days | BUY |  $1,001 - $15,000 | -3.03% | |
Ro Khanna House | Feb 6, 2026 | Jan 29, 2026 | 8 days | SELL | $15,001 - $50,000 | +6.34% | |
Ro Khanna House | Feb 6, 2026 | Jan 23, 2026 | 14 days | BUY | $1,001 - $15,000 | +5.62% | |
 Gilbert Cisneros House | Jan 12, 2026 | Dec 19, 2025 | 24 days | BUY | $1,001 - $15,000 | +7.77% | |
 Julie Johnson House | Jan 15, 2026 | Dec 18, 2025 | 28 days | SELL | $1,001 - $15,000 | +9.51% | |
Julie Johnson House | Dec 11, 2025 | Nov 13, 2025 | 28 days | SELL | $1,001 - $15,000 | +20.09% | |
Gilbert Cisneros House | Dec 15, 2025 | Nov 12, 2025 | 33 days | BUY | $1,001 - $15,000 | +18.99% | |
Ro Khanna House | Dec 8, 2025 | Nov 3, 2025 | 35 days | BUY | $1,001 - $15,000 | +26.90% | |
Gilbert Cisneros House | Nov 18, 2025 | Oct 9, 2025 | 40 days | SELL | $1,001 - $15,000 | +30.71% | |
Ro Khanna House | Oct 3, 2025 | Sep 29, 2025 | 4 days | SELL | $1,001 - $15,000 | +34.10% |
Bristol-Myers Squibb (BMY) congressional trading FAQ
Can members of Congress legally trade Bristol-Myers Squibb (BMY) stock?
Yes. Members of Congress are permitted to trade individual stocks, including Bristol-Myers Squibb (BMY), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. BullishWhales tracks those disclosures; it does not imply any trade was improper.
Are congressional Bristol-Myers Squibb (BMY) trades public?
Yes. Every congressional trade in Bristol-Myers Squibb (BMY) on this page comes from mandatory public STOCK Act disclosure filings, which are filed with a delay and may be revised.
How many times has Congress traded Bristol-Myers Squibb (BMY)?
Members of Congress have disclosed 251 trades in Bristol-Myers Squibb (BMY) worth $6.5M across 45 members, according to public STOCK Act filings.
Which members of Congress have traded Bristol-Myers Squibb (BMY)?
Recent and active filers of Bristol-Myers Squibb (BMY) disclosures include Ro Khanna, Gilbert Cisneros, Julie Johnson. The full member-by-member trade list is on this page.
Do Democrats or Republicans trade Bristol-Myers Squibb (BMY) more?
Across disclosed Bristol-Myers Squibb (BMY) trades, 57% were by Democrats and 43% by Republicans, led by Democrats (57%).
What is the most recent congressional Bristol-Myers Squibb (BMY) trade?
The most recent disclosed Bristol-Myers Squibb (BMY) trade was a purchase by Ro Khanna, filed Mar 8, 2026.
What is Bristol-Myers Squibb (BMY)'s Tide Score?
Bristol-Myers Squibb (BMY) has a BullishWhales Tide Score of 44 (Low Tide). The Tide Score is a 0-100 read blending price forecast, smart-money flow, technicals, and social sentiment; higher is more bullish.
Browse all stocks Congress tradesCongressional trading overviewBristol-Myers Squibb (BMY) stock overview
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. The Tide Score and other figures are generated algorithmically from public filings and market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.